PharmExec Global Marketing:
Having trouble viewing this e-mail? Click here.
PharmExec Direct | From the editors of Pharmaceutical Executive
Send Us Some Feedback
 
| Update My Profile | Advertise With Us | Visit PharmExec.com |
PRINT SUBSCRIBE | DIGITAL SUBSCRIBE
January 29, 2014 | ISSUE NUMBER 5 VOL 1

New Markets, New Media
2014: The Year of Digital Pharma?
A recent survey says digital experience delivery can now make or break a firm it’s no longer just a ‘nice to have’. 2014, then, could be the year that pharma really has to get serious about digital, writes Peter Houston ...Read more

New Markets, New Media
Social Media: Have We Reached the Tipping Point?
The FDA released its draft guidance on the use of “Interactive Promotional Media” this month, ending several years of speculation and finally providing the industry with substantial guidance on its use of digital media
...Read more

New Markets, New Media
On-Demand Marketing Re-invents Customer Relationships
Staying on top of the digital information stream can be difficult for your customers, but plans for a ‘holistic’ healthcare network could make it easier for pharma sales and marketing to build relationships
...Read more

Launch
Checking the Box on Early Commercialization
It may require true “out of the box” thinking, but failure to improve successful launch rates will doom your company to marginalization in the competitive fight for brand affinity — not to mention the prescriber loyalty that keeps medicines in play for the long haul, write Partha & Jayanthi Anbil
...Read more

Forecast
Pharm Exec’s Annual Industry Outlook 2014
For Big Pharma, the merits of strategic focus and operational discipline are more important than ever. As our annual industry outlook confirms, it’s time to be decisive — muddling through is so ‘yesterday’
...Read more

//Fleishman-Hillard appointed Richard Sorian to lead the healthcare division of its office in Washington, DC. //Erik Hawkinson joined New York-based integrated marketing agency WCG as Managing Director. //Consultancy firm 3D Communications named Allison May Rosen as communications lead for its projects related to the US Food and Drug Administration's (FDA) advisory committee.//New York’s Precision Health Media appointed Peter Fontana as Vice President Advertising Sales, Richard O'Connor as Chief Financial Officer, and Andy Chapman as a member of the board of advisors.//

February 24–26: Oncology Commercializtion and Market Access
Philadelphia, PA.


March 18–20: eyeforpharma Barcelona
Barcelona, Spain.


May 8–9: iPharma 2014
New York, NY.


 
Follow Pharm Exec on Twitter
Follow Pharm Exec on Facebook
Follow Pharm Exec on Linkedin

 

 
Quick Links

IMS’s Top 10 Social Media Engagers

The 7 Habits of Highly Effective Competitors

FDA Rolls Out Social Media Guidelines — Slowly